510(k) Report

FDA product code · Radiology

Probe, Uptake, Nuclear

IZDClass I21 CFR 892.1320510(k) exempt30 decisions since 19765 recalls

FDA lists IZD as exempt from 510(k): a device of this type needs no clearance unless one of the limits in 21 CFR 892.9 applies, such as a new intended use or a different fundamental technology. 30 FDA decisions since 1976. 5 recalls name this code, 0 of them Class I. The most-cited predicate is K971167, named by 3 later devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, radiology panel

Twenty years of IZD at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · IZD

1in 2014

2011: 12013: 12014: 1
2007high 1 (2011) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · IZD

Too few IZD 510(k)s in any year since 2007 to give a median.

Recalls per year · IZD

1in 2023

2018: 22020: 12023: 12026 (partial year): 1
2007high 2 (2018) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · IZD

8in 2025

2009: 22012: 12013: 32014: 12015: 12016: 12017: 62018: 42019: 32020: 12021: 12022: 32023: 62024: 72025: 8
2007high 8 (2025) · low 0 (2007)2025

MAUDE reports naming product code IZD, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—02
20100—00
20111—00
20120—01
20131—03
20141—01
20150—01
20160—01
20170—06
20180—24
20190—03
20200—11
20210—01
20220—03
20230—16
20240—07
20250—08
20260—1—
FIG. 1 — IZD by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in IZD? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report